Get started
ABBVIE INCABBVIE INCABBVIE INC

ABBVIE INC

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Bonds

4AB trade ideas

ABBV AUG 2025ABBV is approaching a strong resistance zone after heavy selling volume near 210–215. The stock recently broke higher, but price is testing supply after a fast rally. Institutional absorption was seen at 190 and 195, with 205 now acting as immediate support. Upside target: 212–215 if buyers absorb selling pressure. Downside target: 195, and below that 190 as key support. #ABBV #globaltrade #investment #investing #stockmarket #wealth #realestate #markets #economy #finance #money #forex #trading #price #business #currency #blockchain #crypto #cryptocurrency #airdrop #btc #ethereum #ico #altcoin #cryptonews #Bitcoin #ipo
NYSE:ABBV
by alexpv73
ABBV - Are you Ready?Hello TradingView Family / Fellow Traders. This is Richard, also known as theSignalyst. 📈ABBV has been in a correction phase and it is currently approaching the lower bound of the red and blue channels. Moreover, the green zone is a strong round number $150 and structure! 🏹 Thus, the highlighted blue circle is a strong area to look for buy setups as it is the intersection of structure and lower trendlines acting as non-horizontal support. 📚 As per my trading style: As #ABBV approaches the blue circle, I will be looking for bullish reversal setups (like a double bottom pattern, trendline break , and so on...) 📚 Always follow your trading plan regarding entry, risk management, and trade management. Good luck! All Strategies Are Good; If Managed Properly! ~Rich
NYSE:ABBV
by TheSignalyst
3
$ABBV Breakout About AbbVie, Inc. AbbVie, Inc. is a leading biopharmaceutical company developing and selling treatments for various serious health conditions. Here's a brief overview: * Founded on October 19, 2011 * Headquartered in North Chicago, IL * Focus areas include: + Chronic autoimmune diseases (rheumatology, gastroenterology, dermatology) + Oncology (blood cancers, virology) + Neurological disorders (Parkinson's, metabolic disorders) + Other serious health conditions (HCV, HIV, endometriosis, cystic fibrosis) AbbVie is committed to improving patient outcomes through innovative research and development.
NYSE:ABBVLong
by ImmaculateTony
Major Price Movement Incoming for ABBV!Signalist has detected a precise pattern in NYSE:ABBV FUBO trading activity, signaling that a substantial price movement is imminent. This isn’t a random fluctuation—it’s a carefully analyzed precursor to a significant market event. 📅 What to Expect: ⌛ Timeline: Anticipate a major move within the next 1 to 4 upcoming 3-hour candles. 📈 Monitor the Charts: Keep an eye on ABBV’s price action over the next few candles. Prepare Your Strategy: Whether you’re bullish or bearish, have your trading plan ready to capitalize on the move.
NYSE:ABBV
by SIGNALIST_indicator
Leaning Bullish on ABBV after Strong Reaction to EarningsABBV had a solid reaction to earnings. The tight consolidation over the last few days supports a bullish momentum holding up. Volume declining over the last few days (when price has been declining) typically means a healthy consolidation before a continued rise. While the price may/may not continue down a bit more, if it starts to climb back up, the 201 area would be a place I'd consider an entry (either call option or stock). I'd place a stop around 194, and a first profit target when the price extends again from its 10EMA. That area of 201 for entry will be where the price rises above the moving averages on the 15m and 1h chart time frames, and the 10EMA crossing back above the 20EMA on the 15m timeframe. 1h
NYSE:ABBVLong
by emanuelaelias
3
ABBVIE broke below the 1D MA50. Confirmed sell opportunity.AbbVie Inc. (ABBV) has been trading within a Channel Up pattern since the November 09 2023 Low. Having made a Higher High on September 04 and been rejected at the top of the Channel Up, the price broke and closed aggressively below its 1D MA50 (blue trend-line) three days ago. That is a confirmed technical sell signal. The 1D RSI has been on Lower Highs before the actual High, very similar to the previous top on March 12 2024. That sequence, after breaking below its 1D MA50, extended aggressively towards the 1D MA200 (orange trend-line) and bottomed on the 0.618 Fibonacci retracement level. As a result, we can take a low risk sell now and target a potential contact with the 1D MA200 at $180.00. As far as buying the dip for the long-term is concerned, the most consistent buy signal has been the 1D RSI Bullish Divergence when it forms the first Higher Lows sequence after breaking below the 30.00 oversold barrier. So far that has worked 3 times almost perfectly, with the only exception the May 29 2024 bottom, which still was formed not that far away from the April 26 buy signal. ------------------------------------------------------------------------------- ** Please LIKE 👍, FOLLOW ✅, SHARE 🙌 and COMMENT ✍ if you enjoy this idea! Also share your ideas and charts in the comments section below! This is best way to keep it relevant, support us, keep the content here free and allow the idea to reach as many people as possible. ** ------------------------------------------------------------------------------- 💸💸💸💸💸💸 👇 👇 👇 👇 👇 👇
NYSE:ABBVShort
by TradingShot
2